We are live on ! Find out more
KROS icon

Keros Therapeutics
KROS

113 hedge funds and large institutions have $617M invested in Keros Therapeutics in 2022 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 39 increasing their positions, 25 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

192,133% more call options, than puts

Call options by funds: $5.77M | Put options by funds: $3K

60% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 15

56% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 25

42% more capital invested

Capital invested by funds: $433M → $617M (+$184M)

9% more funds holding

Funds holding: 104 → 113 (+9)

2.03% less ownership

Funds ownership: 72.22% → 70.18% (-2%)

Holders
113
Holders Change
+9
Holders Change %
+8.65%
% of All Funds
1.95%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.05%
New
24
Increased
39
Reduced
25
Closed
15
Calls
$5.77M
Puts
$3K
Net Calls
+$5.76M
Net Calls Change
+$3.93M

Top Buyers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
+$11.9M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$9.14M
3
CIBC Asset Management
CIBC Asset Management
Ontario, Canada
+$5.07M
4
SCM
Soleus Capital Management
Connecticut
+$5.06M
5
SFM
Sphera Funds Management
Israel
+$4.81M

Top Sellers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
-$17M
2
OCA
Octagon Capital Advisors
New York
-$4.21M
3
Allianz Asset Management
Allianz Asset Management
Germany
-$3.82M
4
NCM
Nantahala Capital Management
Connecticut
-$2.29M
5
Morgan Stanley
Morgan Stanley
New York
-$2.02M
Name Holding Trade Value Shares
Change 		Change in
Stake
LSA
101
Leonteq Securities AG
Switzerland
$10.2K – – –
Simplex Trading
102
Simplex Trading
Illinois
$9K +$3.64K +105 +66%
CUAMC
103
China Universal Asset Management Company
China
$9K +$8.35K +241 New
Daiwa Securities Group
104
Daiwa Securities Group
Japan
$3K – – –
US Bancorp
105
US Bancorp
Minnesota
$2K +$485 +14 +34%
National Bank of Canada
106
National Bank of Canada
Quebec, Canada
$1K – – –
Rockefeller Capital Management
107
Rockefeller Capital Management
New York
$1K – – –
LC
108
Lindbrook Capital
California
$1K +$312 +9 +113%
Nisa Investment Advisors
109
Nisa Investment Advisors
Missouri
$1K +$520 +15 New
WFA
110
Wipfli Financial Advisors
Wisconsin
$1K +$728 +21 New
OCA
111
Octagon Capital Advisors
New York
– -$4.21M -152,249 Closed
Two Sigma Investments
112
Two Sigma Investments
New York
– -$1.53M -55,561 Closed
Marshall Wace
113
Marshall Wace
United Kingdom
– -$1.46M -52,934 Closed
AS
114
Altshuler Shaham
Israel
– -$941K -34,074 Closed
Jane Street
115
Jane Street
New York
– -$921K -33,356 Closed
D.E. Shaw & Co
116
D.E. Shaw & Co
New York
– -$582K -21,056 Closed
HS
117
HighVista Strategies
Massachusetts
– -$459K -16,623 Closed
TI
118
Trexquant Investment
Connecticut
– -$396K -14,341 Closed
Bank of Montreal
119
Bank of Montreal
Ontario, Canada
– -$336 -11,613 Closed
DTL
120
Dynamic Technology Lab
Singapore
– -$277K -10,020 Closed
QT
121
Quantbot Technologies
New York
– -$175K -6,364 Closed
PHK
122
Point72 Hong Kong
Hong Kong
– -$28K -1,006 Closed
HNWAG
123
High Net Worth Advisory Group
Florida
– -$14K -500 Closed
Group One Trading
124
Group One Trading
Illinois
– -$3.47K -100 Closed
Federated Hermes
125
Federated Hermes
Pennsylvania
– -$2K -74 Closed
2 3 4
5
6

KROS Hedge Fund Activity: Q3 2022 in Review

113 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Keros Therapeutics (KROS) for Q3 2022, worth a combined $617M — up 42% from $433M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new KROS positions and 15 closed out — a net gain of 9 holders — while 39 added to existing stakes and 25 trimmed.

The largest buyer was Woodline Partners, opening a new position worth an estimated $11.9M. The largest seller was Deep Track Capital, cutting an estimated $17M.

  • 113 institutional investors held Keros Therapeutics (KROS) as of Q3 2022, up from 104 in Q2 2022.
  • Funds reported $617M of Keros Therapeutics stock for Q3 2022, up 42% quarter-over-quarter.
  • 24 funds opened new Keros Therapeutics positions in Q3 2022 and 15 closed out, a net change of +9 holders.
  • The largest Keros Therapeutics buyer in Q3 2022 was Woodline Partners, an estimated $11.9M added.
  • The largest Keros Therapeutics seller in Q3 2022 was Deep Track Capital, an estimated $17M sold.

Based on aggregated 13F filings for Q3 2022.